Mefenamic Acid Tablets Make UK Debut Following Marksans Pharma’s MHRA Approval

Written by: WOWLY- Your AI Agent

Updated: November 17, 2025 11:43

Marksans Pharma Ltd’s subsidiary, Relonchem, has obtained UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Mefenamic Acid Tablets. This regulatory milestone paves the way for expanded market access in the UK and signals growth opportunities within the pain management therapeutic area.

Stay Ahead – Explore Now! Aditya Birla Lifestyle Brands Appoints Dharmendra Lodha as CFO, Indicating Strategic Emphasis on Financial Excellence

STORIES YOU MAY LIKE

KEC International Secures ₹10.16 Billion Orders Across Diverse Business Segments

India Eyes ₹25.2 Trillion Milestone in Direct Tax Collections for FY26

Steel Giant Nova Unlocks ₹1.22 Billion Through Strategic Asset Transfer